Prevalence and outcomes of polycystic kidney disease in African populations: A systematic review

Table 2 Main clinical manifestations at presentation

Ref.	HTN (%)	Pain (%)	Hematuria (%)	Abdominal mass (%)	KFI (%)	ESKD (%)
Hajji et al[4], 2019	58.8	51.9	24.6	66.0	74.7	23.0
Arogundade et al[5], 2018	87.8	68.3	36.6	82.9	100.0	19.5
Chijioke et al[6], 2010	26.9	14.1	NA	NA	32.0	NA
Ogiator et al[7], 2021	42.1	68.4	31.6	NA	63.2	15.8
Mawufemo et al[8], 2018	77.8	63.0	22.2	63.0	63.0	25.9
Fary Ka et al[9], 2010	65.4	52.7	25.4	NA	NA	NA
Okyere et al[10], 2021	50.0	39.0	2.4	NA	81.7	15.9
Laleye et al[11], 2012	59.0	62.0	46.0	43.0	72.0	NA
Abdelwahed et al[12], 2022	57.9	NA	26.3	NA	89.5	NA
Abdelwahed et al[13], 2018	72.2	NA	NA	NA	NA	NA
Pooled prevalence [95%IC]	57.4 [54.2–60.6]	49.1 [45.8–52.3]	24.0 [21.1–26.9]	65.8 [62.2–69.4]	72.1 [69.1–75.1]	21.9 [18.9–24.9]

NA: Not available; HTN: Hypertension; KFI: Kidney function impairment; ESKD: End stage kidney disease.